Presentation ACC 2026 Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement Presenter: Adam Greenbaum March 29, 2026
Presentation ACC 2026 Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial Presenter: Saibal Kar March 28, 2026
Presentation THT 2026 Response to left atrial to coronary sinus shunting in patients with heart failure and atrial fibrilllation Presenter: JoAnn Lindenfeld March 03, 2026
Presentation THT 2026 Advances in Afib Ablation Strategies: What Does the HF Doctor Need To Know? Presenter: Hirad Yarmohammadi March 03, 2026
Presentation THT 2026 Managing Afib: Is There a Difference in HFpEF vs HFrEF Presenter: Nassir F. Marrouche March 03, 2026
Presentation THT 2026 Wearables for Afib Detection — What is the Threshold for Intervention? Presenter: Kola Agboola March 03, 2026
Presentation THT 2026 Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation Presenter: Andrea Russo March 03, 2026
Presentation THT 2026 Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials Presenter: Mark Darkwah March 03, 2026
Presentation THT Abstracts 2026 Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation Presenter: Mark Darkwah March 02, 2026
Presentation THT Abstracts 2026 CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION Presenter: Jaclyn Hayma March 02, 2026
Presentation THT Abstracts 2026 Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction Presenter: Nishanth Katukuri March 02, 2026
Presentation TCT 2025 TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction Presenter: Xiaochun Zhang October 28, 2025
Presentation TCT 2025 TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation Presenter: Kuseme Udoh October 28, 2025
Presentation TCT 2025 TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis Presenter: Adham Ramadan October 28, 2025
Presentation TCT 2025 TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting Presenter: Muhammad Zahid October 28, 2025
Presentation TCT 2025 TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis Presenter: Thomas E. Waggoner October 28, 2025
Presentation TCT 2025 TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention Presenter: Khaled Elnaggar October 28, 2025
Presentation TCT 2025 TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer Presenter: Carlos Eduardo Vergara Uzcategui October 28, 2025
Presentation TCT 2025 TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis Presenter: Mohamed Doma October 28, 2025
Presentation TCT 2025 TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation Presenter: Devi G. Nair October 28, 2025